Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Scalzo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Immunology|April 7, 2011
CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigmsKaren Scalzo-Inguanti, Magdalena Plebanski
Current Topics in Medicinal Chemistry|October 5, 2006
Regulatory T-cells: immunomodulators in health and diseaseKaren Scalzo, Magdalena Plebanski, Vasso Apostolopoulos
Trends in Parasitology|June 26, 2007
Predicting memory: a prospective readout for malaria vaccines?Gabriela Minigo, Karen Scalzo, Katie L Flanagan, et al.
Frontiers in Immunology|August 22, 2013
TNFR2 Expression on CD25(hi)FOXP3(+) T Cells Induced upon TCR Stimulation of CD4 T Cells Identifies Maximal Cytokine-Producing EffectorsChindu Govindaraj, Karen Scalzo-Inguanti, Anja Scholzen, et al.
Expert Review of Vaccines|September 5, 2008
Promising particle-based vaccines in cancer therapySue D Xiang, Karen Scalzo-Inguanti, Gabriela Minigo, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2013
Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironmentChindu Govindaraj, Karen Scalzo-Inguanti, Mutsa Madondo, et al.
Cancers|November 12, 2013
Substantially modified ratios of effector to regulatory T cells during chemotherapy in ovarian cancer patients return to pre-treatment levels at completion: implications for immunotherapyAnthony Park, Chindu Govindaraj, Sue D Xiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Selectively impaired CD8+ but not CD4+ T cell cycle arrest during priming as a consequence of dendritic cell interaction with plasmodium-infected red cellsDodie S Pouniotis, Owen Proudfoot, Violeta Bogdanoska, et al.
Journal of Leukocyte Biology|May 19, 2017
A neutralizing anti-G-CSFR antibody blocks G-CSF-induced neutrophilia without inducing neutropenia in nonhuman primatesKaren Scalzo-Inguanti, Katherine Monaghan, Kirsten Edwards, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2011
Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammationCharles L Hardy, Jeanne S LeMasurier, Gabrielle T Belz, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Immunology|April 7, 2011
CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigmsKaren Scalzo-Inguanti, Magdalena Plebanski
Current Topics in Medicinal Chemistry|October 5, 2006
Regulatory T-cells: immunomodulators in health and diseaseKaren Scalzo, Magdalena Plebanski, Vasso Apostolopoulos
Trends in Parasitology|June 26, 2007
Predicting memory: a prospective readout for malaria vaccines?Gabriela Minigo, Karen Scalzo, Katie L Flanagan, et al.
Frontiers in Immunology|August 22, 2013
TNFR2 Expression on CD25(hi)FOXP3(+) T Cells Induced upon TCR Stimulation of CD4 T Cells Identifies Maximal Cytokine-Producing EffectorsChindu Govindaraj, Karen Scalzo-Inguanti, Anja Scholzen, et al.
Expert Review of Vaccines|September 5, 2008
Promising particle-based vaccines in cancer therapySue D Xiang, Karen Scalzo-Inguanti, Gabriela Minigo, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2013
Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironmentChindu Govindaraj, Karen Scalzo-Inguanti, Mutsa Madondo, et al.
Cancers|November 12, 2013
Substantially modified ratios of effector to regulatory T cells during chemotherapy in ovarian cancer patients return to pre-treatment levels at completion: implications for immunotherapyAnthony Park, Chindu Govindaraj, Sue D Xiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Selectively impaired CD8+ but not CD4+ T cell cycle arrest during priming as a consequence of dendritic cell interaction with plasmodium-infected red cellsDodie S Pouniotis, Owen Proudfoot, Violeta Bogdanoska, et al.
Journal of Leukocyte Biology|May 19, 2017
A neutralizing anti-G-CSFR antibody blocks G-CSF-induced neutrophilia without inducing neutropenia in nonhuman primatesKaren Scalzo-Inguanti, Katherine Monaghan, Kirsten Edwards, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2011
Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammationCharles L Hardy, Jeanne S LeMasurier, Gabrielle T Belz, et al.
Pageof 2